361130BR
Mar 02, 2023
USA
Job Description
Bringing life-changing medicines to millions of people, Novartis sits at the intersection of cutting-edge medical science and innovative digital technology! As a global company, the resources and opportunities for growth and development are plentiful including global and local cross functional careers, a diverse learning suite of thousands of programs & an in-house marketplace for rotations & project work. With a strong medicines pipeline our current transformation will not just deliver growth for our business but continue to allow us to bring innovative medicines to patients quickly.
Associate Director, Early Access is dedicated to supporting innovative and winning market access strategies, optimizing the payer value proposition and access-relevant evidence packages for early-stage assets, in partnership with the Global TA teams.
In partnership with the Early Access Directors and working closely with R&D (NIBR & GDD), Strategy & Growth (S&G) and Global & US Strategic TAs, Associate Director, Early Access will enable cross-functional teams to translate early science into compelling payer and HCS value propositions and solutions, deliver against access and payer evidence requirements and secure wide patient access and affordability. They will ensure access landscaping and payer evidence requirements are built into investment decisions, disease, and early product TPPs, clinical development plans, integrated product strategies, indication sequencing/asset maximization, and tollgate investment decisions.
Your key responsibilities:
Your responsibilities include, but are not limited to:
• Support several Novartis assets and programs alongside the early lifecycle from pre-POC to FDP, up until assets transition from the Global TA teams to the International TA teams.
• With Early Access Directors and the Global TAs, support the development of Access strategies with specific focus on priority countries (US, CN, DE, JP), major HTA architypes (e.g., UK/CAN) and Budget Impact archetypes (e.g., Italy and/or Spain) needs and feasibility.
• Work in close partnership with Early Access Directors, strategic TAs, cross-functional teams, GPTs, S&G, Regional and priority Country teams to maximize access for early IM assets.
• With key stakeholders, support and execute winning and innovative cross-functional and access strategies and solutions for several early-stage assets with specific focus on priority countries (US, CN, DE, JP), major HTA architypes (e.g., UK/CAN) and Budget Impact archetypes (e.g., Italy and/or Spain) needs and feasibility.
• Create collaborative partnerships internally and externally to break down silos; partner, collaborate and influence externally and internally across strategic TAs, GPTs, S&G, Regional and priority Country cross-functional teams to maximize access for early IM assets and to shape the future of healthcare.
• Enable cross-functional teams to translate early science into compelling payer and HCS value propositions and solutions, deliver against access and payer evidence requirements and secure wide patient access and affordability.
• Investigate access landscape and payer evidence requirements for inclusion into investment decisions, disease, and early product TPPs, clinical development plans, integrated product strategies, indication sequencing/asset maximization, and tollgate investment decisions.
• Work with Market Access Directors and countries to understand insights and feedback, integrate into winning access and pricing strategies and tactics, incorporating payer perspective in overarching cross-functional product strategies and investment decisions
This position will be located at the East Hanover, NJ site and will not have the ability to be located remotely. This position will require 20% travel as defined by the business (domestic and/ or international). Please note that this role would not provide relocation and only local candidates will be considered.
The pay range for this position at commencement of employment is expected to be between $174,400 and $261,600/year; however, while salary ranges are effective from 1/1/23 through 12/31/23, fluctuations in the job market may necessitate adjustments to pay ranges during this period. Further, final pay determinations will depend on various factors, including, but not limited to geographical location, experience level, knowledge, skills and abilities. The total compensation package for this position may also include other elements, including a sign-on bonus, restricted stock units, and discretionary awards in addition to a full range of medical, financial, and/or other benefits (including 401(k) eligibility and various paid time off benefits, such as vacation, sick time, and parental leave), dependent on the position offered. Details of participation in these benefit plans will be provided if an employee receives an offer of employment. If hired, employee will be in an “at-will position” and the Company reserves the right to modify base salary (as well as any other discretionary payment or compensation program) at any time, including for reasons related to individual performance, Company or individual department/team performance, and market factors.
Associate Director, Early Access is dedicated to supporting innovative and winning market access strategies, optimizing the payer value proposition and access-relevant evidence packages for early-stage assets, in partnership with the Global TA teams.
In partnership with the Early Access Directors and working closely with R&D (NIBR & GDD), Strategy & Growth (S&G) and Global & US Strategic TAs, Associate Director, Early Access will enable cross-functional teams to translate early science into compelling payer and HCS value propositions and solutions, deliver against access and payer evidence requirements and secure wide patient access and affordability. They will ensure access landscaping and payer evidence requirements are built into investment decisions, disease, and early product TPPs, clinical development plans, integrated product strategies, indication sequencing/asset maximization, and tollgate investment decisions.
Your key responsibilities:
Your responsibilities include, but are not limited to:
• Support several Novartis assets and programs alongside the early lifecycle from pre-POC to FDP, up until assets transition from the Global TA teams to the International TA teams.
• With Early Access Directors and the Global TAs, support the development of Access strategies with specific focus on priority countries (US, CN, DE, JP), major HTA architypes (e.g., UK/CAN) and Budget Impact archetypes (e.g., Italy and/or Spain) needs and feasibility.
• Work in close partnership with Early Access Directors, strategic TAs, cross-functional teams, GPTs, S&G, Regional and priority Country teams to maximize access for early IM assets.
• With key stakeholders, support and execute winning and innovative cross-functional and access strategies and solutions for several early-stage assets with specific focus on priority countries (US, CN, DE, JP), major HTA architypes (e.g., UK/CAN) and Budget Impact archetypes (e.g., Italy and/or Spain) needs and feasibility.
• Create collaborative partnerships internally and externally to break down silos; partner, collaborate and influence externally and internally across strategic TAs, GPTs, S&G, Regional and priority Country cross-functional teams to maximize access for early IM assets and to shape the future of healthcare.
• Enable cross-functional teams to translate early science into compelling payer and HCS value propositions and solutions, deliver against access and payer evidence requirements and secure wide patient access and affordability.
• Investigate access landscape and payer evidence requirements for inclusion into investment decisions, disease, and early product TPPs, clinical development plans, integrated product strategies, indication sequencing/asset maximization, and tollgate investment decisions.
• Work with Market Access Directors and countries to understand insights and feedback, integrate into winning access and pricing strategies and tactics, incorporating payer perspective in overarching cross-functional product strategies and investment decisions
This position will be located at the East Hanover, NJ site and will not have the ability to be located remotely. This position will require 20% travel as defined by the business (domestic and/ or international). Please note that this role would not provide relocation and only local candidates will be considered.
The pay range for this position at commencement of employment is expected to be between $174,400 and $261,600/year; however, while salary ranges are effective from 1/1/23 through 12/31/23, fluctuations in the job market may necessitate adjustments to pay ranges during this period. Further, final pay determinations will depend on various factors, including, but not limited to geographical location, experience level, knowledge, skills and abilities. The total compensation package for this position may also include other elements, including a sign-on bonus, restricted stock units, and discretionary awards in addition to a full range of medical, financial, and/or other benefits (including 401(k) eligibility and various paid time off benefits, such as vacation, sick time, and parental leave), dependent on the position offered. Details of participation in these benefit plans will be provided if an employee receives an offer of employment. If hired, employee will be in an “at-will position” and the Company reserves the right to modify base salary (as well as any other discretionary payment or compensation program) at any time, including for reasons related to individual performance, Company or individual department/team performance, and market factors.
Diversity & Inclusion / EEO
The Novartis Group of Companies are Equal Opportunity Employers and take pride in maintaining a diverse environment. We do not discriminate in recruitment, hiring, training, promotion or other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, gender identity or expression, marital or veteran status, disability, or any other legally protected status. We are committed to building diverse teams, representative of the patients and communities we serve, and we strive to create an inclusive workplace that cultivates bold innovation through collaboration and empowers our people to unleash their full potential.
Minimum Requirements
What you’ll bring to the role:
Essential:
• 5+ years of experience at pharmaceutical companies or life science consulting companies with at least 2 years in Market Access roles
• Knowledge in the areas of market access strategy & execution, payer-relevant evidence strategy & generation, payer negotiations, local formulary management
• Understanding of payer/HTA environment and evolution across countries
• Ability to deliver in cross-functional matrix organization and build strong relationships including in virtual environment
Preferred
Desirable Requirements:
• Postgraduate Degree in a relevant discipline e.g., medicine, sciences, business administration, health policy, health economic
• Proven track record in driving implementation of large-scale projects in an agile way
• Previous cross-functional experience in Early Products (access, marketing or other function is advantage)
• A strong track record in interacting and negotiating with external stakeholders (physicians, payers, industry bodies, governments)
#transformingforgrowth
Why Novartis?
766 million lives were touched by Novartis medicines in 2021, and while we're proud of this, we know there is so much more we could do to help improve and extend people's lives.
We believe new insights, perspectives and ground-breaking solutions can be found at the intersection of medical science and digital innovation. That a diverse, equitable and inclusive environment inspires new ways of working.
We believe our potential can thrive and grow in an unbossed culture underpinned by integrity, curiosity and flexibility. And we can reinvent what's possible, when we collaborate with courage to aggressively and ambitiously tackle the world's toughest medical challenges. Because the greatest risk in life, is the risk of never trying!
Imagine what you could do here at Novartis!
Commitment to Diversity & Inclusion:
Novartis is committed to building an outstanding, inclusive work environment and diverse
teams representative of the patients and communities we serve.
Accessibility and Reasonable Accommodations:
The Novartis Group of Companies are committed to working with and providing reasonable accommodation to individuals with disabilities. If, because of a medical condition or disability, you need a reasonable accommodation for any part of the application process, or in order to perform the essential functions of a position, please send an e-mail to [email protected] call +1 (877) 395-2339 and let us know that nature of your request and your contact information. Please include the job requisition number in your message.
Join our Novartis Network: If this role is not suitable to your experience or career goals but you wish to stay connected to hear more about Novartis and our career opportunities, join the Novartis Network here: https://talentnetwork.novartis.com/network
Essential:
• 5+ years of experience at pharmaceutical companies or life science consulting companies with at least 2 years in Market Access roles
• Knowledge in the areas of market access strategy & execution, payer-relevant evidence strategy & generation, payer negotiations, local formulary management
• Understanding of payer/HTA environment and evolution across countries
• Ability to deliver in cross-functional matrix organization and build strong relationships including in virtual environment
Preferred
Desirable Requirements:
• Postgraduate Degree in a relevant discipline e.g., medicine, sciences, business administration, health policy, health economic
• Proven track record in driving implementation of large-scale projects in an agile way
• Previous cross-functional experience in Early Products (access, marketing or other function is advantage)
• A strong track record in interacting and negotiating with external stakeholders (physicians, payers, industry bodies, governments)
#transformingforgrowth
Why Novartis?
766 million lives were touched by Novartis medicines in 2021, and while we're proud of this, we know there is so much more we could do to help improve and extend people's lives.
We believe new insights, perspectives and ground-breaking solutions can be found at the intersection of medical science and digital innovation. That a diverse, equitable and inclusive environment inspires new ways of working.
We believe our potential can thrive and grow in an unbossed culture underpinned by integrity, curiosity and flexibility. And we can reinvent what's possible, when we collaborate with courage to aggressively and ambitiously tackle the world's toughest medical challenges. Because the greatest risk in life, is the risk of never trying!
Imagine what you could do here at Novartis!
Commitment to Diversity & Inclusion:
Novartis is committed to building an outstanding, inclusive work environment and diverse
teams representative of the patients and communities we serve.
Accessibility and Reasonable Accommodations:
The Novartis Group of Companies are committed to working with and providing reasonable accommodation to individuals with disabilities. If, because of a medical condition or disability, you need a reasonable accommodation for any part of the application process, or in order to perform the essential functions of a position, please send an e-mail to [email protected] call +1 (877) 395-2339 and let us know that nature of your request and your contact information. Please include the job requisition number in your message.
Join our Novartis Network: If this role is not suitable to your experience or career goals but you wish to stay connected to hear more about Novartis and our career opportunities, join the Novartis Network here: https://talentnetwork.novartis.com/network
ONCOLOGY
ONCOLOGY BU
USA
East Hanover, NJ
Novartis Corporation
Market Access
Full Time
Regular
No
